Physician profile
Scott B Patterson
NPI 1003904970
$1,213.13
in general payments reported to CMS, 2019-2025
17 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.50 · 2020: $199 · 2021: $400 · 2022: $188 · 2023: $22.13 · 2024: $99.69 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $618.15 | 2020-2022 | |
| Ge Healthcare | $110.56 | 2025 | |
| Sun Pharmaceutical Industries INC. | $87.44 | 2022-2025 | Winlevi, Absorica Ld |
| Abbvie INC. | $53.82 | 2022-2024 | |
| Ucb, INC. | $52.16 | 2025 | Bimzelx |
| Janssen Biotech, INC. | $37.95 | 2022-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $36.51 | 2025 | Dupixent |
| Medline Industries LP | $35.15 | 2021 | |
| Incyte Corporation | $27.71 | 2024 | Opzelura |
| Lilly USA, LLC | $23.73 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.55 | 2025 | Spevigo |
| Genzyme Corporation | $21.84 | 2025 | |
| Pulmonx Corporation | $20.75 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.51 | 2024 | Siliq |
| Janssen Pharmaceuticals, INC | $14.99 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $14.81 | 2021 | |
| Merck Sharp & Dohme LLC | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.